Category: Berkeley

user warning: Table './cburns2_drpl/accesslog' is marked as crashed and should be repaired query: INSERT INTO accesslog (title, path, url, hostname, uid, sid, timer, timestamp) values(' Please log in to access this content.', 'node/948', '', '38.107.179.230', 0, '8fe97a22ba3842e8c3d67eba43c5a2d2', 486, 1329116615) in /home/cburns2/public_html/luminogenics/modules/statistics/statistics.module on line 64.

Scholarships Available for BioExec Institute 2010

UC Berkeley, Deloitte and Prescience, Intl. are proud to offer 10 scholarships to the BioExec Institute 2010. Part of the success of this internationally-renowned program has been the diversity and depth of its participants, which has created a strong and powerful alumni network in this industry. We would therefore like to offer scholarships to the leadership of small companies with annual revenues under $10M and to academics, as well as employees of governmental and/or non-profit organizations. These scholarships finance nearly 50% of an attendee's program registration fee.

This is a rolling application process. Please click here to download the application form and submit to Chelsea Hewitt at chelsea@prescienceintl.com. You will be notified if your application is accepted within one week of your submission. Some of this year's faculty and speakers include:

Mervyn J. Turner, Ph.D., Chief Strategy Officer, Merck & Co. Inc. & Sr. Vice President, Emerging Markets, Merck Research Laboratories
Mark Edwards, President, Deloitte Recap, LLC
Barbara Ryan, Managing Director, Deutsche Bank
Dave Summa, Board of Directors, Sequoia Pharmaceuticals, Acumen Pharmaceuticals, and Agrivida, Inc.
Christopher S. Boerner, Group Product Manager, Xolair Marketing, Genentech
David Kessler, MD, JD, Best Selling Author and Former Commissioner of the US Food and Drug Administration (FDA)
Martin Babler, President and CEO, Talima Therapeutics Inc.
Casper DeClerq, Venture Partner, US Venture Partners
Scott Evangelista, Principal, National Commercial Practice Leader, Deloitte Consulting LLP
Dennis Schmatz, PhD, President, Medicines for Malaria Venture NA; Chair - Expert Scientific Advisory Board (ESAC) Medicines for Malaria Venture, Board Member,Medicines for Malaria Venture
Keith Donnermeyer, Partner and National Life Sciences Sector Leader, Deloitte & Touche LLP
Abhay Joshi, PhD, President & CEO, Alvine Pharmaceuticals
Brian McRee, Director, Commercial Supply Planning, Genentech
Kuo Bianchini Tong, Founder & President, Quorum Consulting

Co-produced by UC Berkeley, Deloitte and Prescience Intl, the BioExec Institute brings together director and VP-level management for this six-day interactive program [3 modules of 2 days each] on Oct 7-8, Nov 4-5 and Dec. 7-8, 2010. For more information or to register, visit http://executive.berkeley.edu/programs/bioexec/index.html.